SCHEMBL3716652

SCHEMBL3716652

O=C(O)/C(F)=C\c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.56
AKR1C1 Q04828 1/20 0.54
CYP2C9 P11712 2/20 0.48
CYP3A4 P08684 1/20 0.48
TP53 P04637 1/20 0.47
HTT P42858 2/20 0.46
ALDH1A1 P00352 4/20 0.45
TSHR P16473 1/20 0.45
MAPT P10636 3/20 0.43
RECQL P46063 2/20 0.43
LMNA P02545 2/20 0.43
HDAC3 O15379 1/20 0.43
TNKS O95271 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HCAR2 Q8TDS4 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211524 1.00 AKR1C3 (0.56) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL2914673 1.00 AKR1C3 (0.56) AKR1C3AKR1C1CYP2C9CYP3A4TP53
Hydrochloric Acid SCHEMBL6818657 0.98 AKR1C3 (0.54) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL8516515 0.92 AKR1C3 (0.48) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL7074200 0.87 TP53 (0.66) AKR1C3AKR1C1TP53HTTTSHR
SCHEMBL7074203 0.87 TP53 (0.66) AKR1C3AKR1C1TP53HTTTSHR
SCHEMBL11179955 0.86 AKR1C3 (0.50) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL11179967 0.86 AKR1C3 (0.50) AKR1C3AKR1C1CYP2C9CYP3A4TP53
SCHEMBL19712515 0.85 ALDH1A1 (0.46) AKR1C3AKR1C1CYP2C9CYP3A4ALDH1A1
SCHEMBL19712514 0.85 ALDH1A1 (0.46) AKR1C3AKR1C1CYP2C9CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150274633-A2 PAIN RELIEF COMPOUNDS UNIVERSITÉ CLERMONT AUVERGNE (FR) 2015-10-01 US disclosed
US-20150038466-A1 PAIN RELIEF COMPOUNDS ECOLE NATIONALE SUPERIEURE DE CHIMIE DE CLERMONT FERRAND (FR) 2015-02-05 US disclosed
WO-2010112092-A1 COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULARY DYSTROPHY BIOMARIN IGA, LTD. (BS) 2010-10-07 WO disclosed
CN-100445285-C Nicotinic acetylcholine receptor ligands ASTRAZENECA AB (SE) 2008-12-24 CN disclosed
US-20070244097-A1 Nicotinic AcetylcholineReceptor Ligands ASTRAZENECA AB (SE) 2007-10-18 US disclosed
CN-1902204-A Nicotinic acetylcholine receptor ligands ASTRAZENECA AB (SE) 2007-01-24 CN disclosed
EP-1699802-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AstraZeneca AB (SE) 2006-09-13 EP disclosed
WO-2005061511-A1 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2005-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038466-A1 PAIN RELIEF COMPOUNDS OPRL1, OPRK1, TRPV1 AKR1C3 1085/4885AKR1C1 1516/4885CYP2C9 3721/4885
US-20150274633-A2 PAIN RELIEF COMPOUNDS OPRL1, OPRK1, TRPV1 AKR1C3 1085/4885AKR1C1 1516/4885CYP2C9 3721/4885
US-20070244097-A1 Nicotinic AcetylcholineReceptor Ligands CHRNG, CHRNE, CHRNA1 AKR1C3 1677/4885AKR1C1 1682/4885CYP2C9 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.